Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /CNW/ - Specific Biologics Inc. ("Specific"), a ...

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and ...

Specific Biologics Inc. ("Specific"), a biotechnology company developing industry-leading in vivo genome editing medicines to treat the untreatable, today announced that together with Western ...

Romano-Ward syndrome, the most common congenital long QT disorder, often causes exertion- or stimulus-triggered syncope and ...

Google DeepMind has named Jasjeet "Jas" Sekhon its new Chief Strategy Officer on March 18. Sekhon is not a product executive or a Silicon Valley veteran. He is a statistician, one of the most ...

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and projected to reach US$ 1,081.9 million ...

The simulator takes into account forecasted demand in each region, transportation costs, and the operational capacity of each warehouse.

Researchers at the European Molecular Biology Laboratory (EMBL) in Germany have unveiled an artificial intelligence system designed to ...

AI in life sciences presents key opportunities in drug discovery, personalized medicine, and diagnostics by leveraging vast datasets for precise, cost-effective solutions. Growth is driven by ...

Think of FEA as the ultimate GPS for government agencies trying to navigate the messy but exciting world of AI without crashing their systems.

A powerful new real-world data platform could transform how scientists predict and understand Alzheimer’s disease and ...

In most boardrooms, the final decision still comes down to a small circle of leaders weighing a narrow set of choices. Yet the problems they face now contain thousands, sometimes millions, of possible ...